Las Vegas, USA, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Vascular Access Devices Market is Expected to Surge at a Significant CAGR of 6.64% and is also Contemplated to Reach Upto USD 6.13 Billion by 2026, Estimates DelveInsight The Vascular Access Device market is anticipated to grow tremendously in the coming years due to many factors which include the rising prevalence of end-stage renal diseases and the rising number of vascular access surgeries, these are striving the Vascular Access Devices demand, thus driving the growth of Vascular Access Device market. DelveInsight''s Vascular Access Devices Market Insights and Forecast report provides the current and forecast Vascular Access Devices, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Vascular Access Devices. Some of the essential takeaways from the Vascular Access Devices Market report: According to DelveInsight analysis, North America is expected to dominate the overall Vascular Access Devices Market during the forecast period.
AngioDynamics (ANGO) registers strong revenue growth across the majority of its GBUs, as well as in domestic and international revenues in fiscal 2022 Q2.
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q2 2022 Results - Earnings Call Transcript

AngioDynamics EPS misses by $0.02, beats on revenue

12:02pm, Thursday, 06'th Jan 2022 Seeking Alpha
AngioDynamics (ANGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology,
Equities analysts expect AngioDynamics, Inc. (NASDAQ:ANGO) to announce sales of $77.97 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for AngioDynamics earnings, with the lowest sales estimate coming in at $77.22 million and the highest estimate coming in at $78.60 million. AngioDynamics posted sales of $72.77 million during []
The Interventional Oncology Devices Market report makes available the basic information about industry, definition, classification, application, industry chain structure, industry overview, and international market analysis. As per this report, the market is expected to grow at a substantial Compound Annual
Los Angeles, United State: The global Endovenous Laser Therapy market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section

Citadel Advisors LLC Cuts Stake in AngioDynamics, Inc. (NASDAQ:ANGO)

09:26am, Monday, 06'th Dec 2021 Dakota Financial News
Citadel Advisors LLC cut its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 35.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,644 shares of the medical instruments suppliers stock after selling 37,414 shares during the quarter. Citadel Advisors LLCs holdings []

AngioDynamics (NASDAQ:ANGO) Downgraded by Zacks Investment Research

07:44am, Sunday, 05'th Dec 2021 Dakota Financial News
Zacks Investment Research lowered shares of AngioDynamics (NASDAQ:ANGO) from a strong-buy rating to a hold rating in a research report report published on Wednesday, Zacks.com reports. The brokerage currently has $27.00 target price on the medical instruments suppliers stock. According to Zacks, AngioDynamics uptick in year-over-year revenues and solid performances across two of its GBUs []

AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Comerica Bank

11:56am, Thursday, 02'nd Dec 2021 Dakota Financial News
Comerica Bank trimmed its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 7.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 35,852 shares of the medical instruments suppliers stock after selling 2,877 shares during the quarter. Comerica Banks holdings in AngioDynamics were worth []
Zacks Investment Research cut shares of AngioDynamics (NASDAQ:ANGO) from a strong-buy rating to a hold rating in a research report sent to investors on Wednesday, Zacks.com reports. The brokerage currently has $27.00 price objective on the medical instruments suppliers stock. According to Zacks, AngioDynamics uptick in year-over-year revenues and solid performances across two of its []
Varicose Vein Treatment Market 2021 Overview: This research report categorizes the Varicose Vein Treatment market by top vendors, region, type, and end-user. this report also lessons the global Varicose Vein Treatment market status, competitive landscape and analysis, market size and share,
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE